AllSquare Wealth Management’s Bionano Genomics BNGO Stock Holding History

AllSquare Wealth Management’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$5	Hold	3	–	–	﹤0.01%	536
2025 Q2	$10	Hold	3	–	–	﹤0.01%	535
2025 Q1	$8	Hold	3	–	–	﹤0.01%	533
2024 Q4	$58	Hold	3	–	–	﹤0.01%	527
2024 Q3	$91	Hold	3	–	–	﹤0.01%	526
2024 Q2	$136	Hold	3	–	–	﹤0.01%	518
2024 Q1	$222	Hold	3	–	–	﹤0.01%	512
2023 Q4	$378	Hold	3	–	–	﹤0.01%	503
2023 Q3	$606	Hold	3	–	–	﹤0.01%	502
2023 Q2	$1.38K	Hold	3	–	–	﹤0.01%	497
2023 Q1	$2.22K	Hold	3	–	–	﹤0.01%	470
2022 Q4	$2.92K	Hold	3	–	–	﹤0.01%	445
2022 Q3	$4K	Hold	3	–	–	﹤0.01%	423
2022 Q2	$3K	Hold	3	–	–	﹤0.01%	441
2022 Q1	$5K	Hold	3	–	–	﹤0.01%	423
2021 Q4	$6K	Hold	3	–	–	﹤0.01%	413
2021 Q3	$11K	Hold	3	–	–	0.01%	359
2021 Q2	$15K	Hold	3	–	–	0.01%	352
2021 Q1	$16K	Hold	3	–	–	0.01%	337
2020 Q4	$6K	Hold	3	–	–	﹤0.01%	375
2020 Q3	$1K	Buy	+3	New	+$1.16K	﹤0.01%	446

Other funds holding BNGO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllSquare Wealth Management's BNGO Position: Q3 2025 in Review

AllSquare Wealth Management held its Bionano Genomics (BNGO) position steady in Q3 2025 at 3 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #536.

AllSquare Wealth Management first reported a position in BNGO in Q3 2020 and has held it in 21 quarters since. The position peaked at $16K in Q1 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q3 2025.

AllSquare Wealth Management held 3 shares of Bionano Genomics worth $5 as of Q3 2025.
AllSquare Wealth Management left its Bionano Genomics share count unchanged in Q3 2025.
Bionano Genomics made up ﹤0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #536 holding.
AllSquare Wealth Management first reported a position in Bionano Genomics in Q3 2020 and has held it in 21 quarters since.
AllSquare Wealth Management's Bionano Genomics position peaked at $16K in Q1 2021.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.